KRAS and neoplasm: Thirteen MSI tumours without MLH1 methylation displayed more severe mutation profiles (11 had an APC defect, 4 KRAS, 2 CTNNB1 and 3 TP53 mutations, and only 1 showed no other genetic defect than MSI).